益丰药房: 益丰药房关于募集资金委托理财进展的公告

Summary of Key Points Core Viewpoint - The company has announced the progress of its entrusted wealth management using idle raised funds, indicating a strategic approach to optimize fund allocation and enhance investment returns while ensuring that the main business operations remain unaffected [1][2]. Group 1: Wealth Management Details - The company has approved the use of idle raised funds for wealth management, with a maximum limit of 219 million yuan, valid for 12 months from the board's approval date [2]. - The company has purchased a structured deposit product named "智汇系列进取型看涨三层区间 59 天结构性存款" from China Merchants Bank for 10 million yuan, with a term of 59 days [1][4]. - Additionally, the company has invested 9 million yuan in a structured deposit product from Shanghai Pudong Development Bank, with a term of 29 days [1][4]. Group 2: Financial Impact and Measures - The investment in short-term wealth management products is expected to generate certain investment returns, thereby enhancing the company's performance and providing better returns for shareholders [5]. - The company emphasizes that the wealth management products chosen are of high safety, good liquidity, and low risk, ensuring that the investment does not affect the normal operation of the company's main business [5]. - The company will conduct audits on the investment situation and report any issues to the audit committee promptly [5].